Monitor the July 17 conference call for deal rationale and synergy details. Watch for definitive agreement execution and regulatory clearance; the earnout structure suggests confidence in near-term performance. IPG's cash funding avoids dilution, a positive for shareholders.
Price Chart
Executive Summary
IPG Photonics announced a binding offer to acquire Lumibird Medical for €300 million (plus up to €50 million earnout) in cash, funded from cash on hand. The acquisition adds a high-margin medical laser business with FY2025 revenue of €112.2 million and EBITDA margin of 21.5%, expected to be accretive to gross margin, EBITDA, and adjusted EPS. The deal expands IPG's addressable market by ~$1 billion and is expected to close in Q4 2026.
Key Facts
- Purchase price of €300 million on a cash-free, debt-free basis, plus up to €50 million contingent earnout based on 2026/2027 performance.
- Lumibird Medical reported FY2025 revenue of €112.2 million and EBITDA of €24.1 million (21.5% margin).
- Acquisition expected to be accretive to gross margin, EBITDA, and adjusted EPS.
- Adds approximately $1 billion in addressable market for IPG's Advanced Solutions portfolio.
- Expected to close in Q4 2026, subject to works council consultation and customary conditions.
Financial Impact
€300 million purchase price plus up to €50 million earnout; Lumibird Medical FY2025 revenue €112.2M, EBITDA €24.1M
Risk Factors
- Integration risk and potential disruption to Lumibird Medical's operations.
- Regulatory approvals and French works council consultation could delay or alter terms.
- Earnout targets may not be achieved, reducing total consideration but also signaling performance risk.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3328860 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 12d ago | Institutional Cluster | $73.76 | awaiting T+20 | — | $74.34 (+0.79%) |
Sep 23, 2026 4w ago | Court Ruling | $77.42 $69.41 | ▲ +10.35% | ▲ +9.93% | $74.34 (+3.98%) |
Sep 3, 2026 7w ago | Insider Cluster | $78.00 $83.60 | ▲ +7.18% | ▲ +6.33% | $74.34 (−4.69%) |
Aug 6, 2026 11w ago | Insider Cluster | $90.23 $78.00 | ▼ −13.55% | ▼ −13.16% | $74.34 (−17.61%) |
Aug 4, 2026 11w ago | Insider Cluster | $91.75 $76.48 | ▼ −16.64% | ▼ −16.04% | $74.34 (−18.98%) |
Aug 4, 2026 12w ago | 8-K | $94.07 $75.20 | ▼ −20.06% | ▼ −18.82% | $74.34 (−20.97%) |
Jul 17, 2026 14w ago | 8-K | $104.33 $85.79 | ▼ −17.77% | ▼ −22.22% | $74.34 (−28.75%) |
Jul 16, 2026 14w ago | Press Release | $104.33 $85.79 | ▼ −17.77% | ▼ −22.22% | $74.34 (−28.75%) |
Jul 1, 2026 16w ago | Insider Cluster | $105.27 $85.06 | ▼ −19.20% | ▼ −19.50% | $74.34 (−29.38%) |
Jun 11, 2026 19w ago | Institutional Cluster | $111.19 $108.03 | ▼ −2.84% | ▼ −4.73% | $74.34 (−33.14%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers